Advanced Medical Solutions Group plc (AMS.L) Stock
Advanced Medical Solutions Group plc

Company profile
Advanced Medical Solutions Group reported revenue of 228.94 million GBP for fiscal year 2025, and net income of 9.95 million GBP. That is a net profit margin of 4.3% for fiscal year 2025. Its largest business segment, Surgical, brought in 76% of segment revenue in fiscal year 2024; Rest of Europe was the largest region with 26%. Our analysis of its filings shows revenue growing from 126.21 million GBP in fiscal year 2023 to 228.94 million GBP in fiscal year 2025, 34.7% a year on average. Advanced Medical Solutions Group reports about 1,800 full-time employees.
What stands out
- Revenue rose 29.0% in fiscal year 2025, from 177.52 million GBP in fiscal year 2024, after a rise of 40.7% the year before.
Figures from company filings; latest fiscal year ended December 31, 2025.
About Advanced Medical Solutions Group plc
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally. It offers surgical products, such as tissue adhesives, sutures and clips, haemostats, biosurgical, internal fixation devices, infection control, and internal sealants. The company also provides collagens, bone substitutes, resorbable fixation systems, vascular temporary occlusion, dressings, silicone wound contact layers, surgical supplies, debridement, hydrogels, and laparoscopic instruments. It sells its products under the LIQUIFIX, Peters Surgical, Ifabond, INTEGUSEAL, LiquiBand, RESORBA, LiquiBandFix8, Seal-G, Vitalitec, and ActivHeal brand names. The company provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Largest shareholders
- Investec Wealth & Investment Ltd.5.94%
- Canaccord Genuity Asset Management Ltd.4.32%
- Société Générale Gestion SA4.29%
- JPMorgan Securities Plc (Market-Maker)4.26%
- Alpine Associates Management, Inc.3.58%
Share of the company, as of September 25, 2026
Leadership
- Andrew Christopher Meredith BSc (Hons) — CEO & Executive Director, 59
- Edward Johnson ACA — CFO, ESG Lead & Executive Director, 53
- Alexandra Dietrich Ph.D. — Chief Operating Officer, 50
- Cathy Tomlinson — Chief People Officer
- Ross McDonald — Chief Commercial Officer
How much revenue does Advanced Medical Solutions Group make?
Advanced Medical Solutions Group reported 228.94 million GBP in revenue for fiscal year 2025, up 29.0% from 177.52 million GBP in fiscal year 2024.
What is Advanced Medical Solutions Group's largest business segment?
Surgical, with 135.77 million GBP or 76% of segment revenue in fiscal year 2024. Next: Woundcare (24%).
Where does Advanced Medical Solutions Group make most of its revenue?
Rest of Europe: 26% of revenue by region in fiscal year 2024, followed by United States of America (24%).
What companies are similar to Advanced Medical Solutions Group?
Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include ConvaTec Group PLC (CTEC.L), SDI Group plc (SDI.L), Verici Dx plc (VRCI.L).
How has Advanced Medical Solutions Group's revenue changed over the last 5 fiscal years?
Revenue by fiscal year: FY2021, 108.60 million GBP; FY2022, 124.33 million GBP; FY2023, 126.21 million GBP; FY2024, 177.52 million GBP; FY2025, 228.94 million GBP.
Company Information
Data as of .
How to cite: DataPorium, “Advanced Medical Solutions Group plc (AMS.L)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/AMS.L